Aydin Yildirim1, Hanefi Cakir2, Necip Kara2, Hasim Uslu2, Bulent Gurler2, Engin Bilge Ozgurhan2, Hatice Nur Colak2. 1. From the Departments of Ophthalmology, Fatih University Medical Faculty Hospital (Yildirim, Uslu, Gurler, Colak), Gaziantep Sehitkamil State Hospital (Kara), and Beyoglu Eye Education and Research Hospital (Ozgurhan), and Turkiye Hospital Eye Clinic (Cakir), Istanbul, Turkey. Electronic address: drayldrm@yandex.com. 2. From the Departments of Ophthalmology, Fatih University Medical Faculty Hospital (Yildirim, Uslu, Gurler, Colak), Gaziantep Sehitkamil State Hospital (Kara), and Beyoglu Eye Education and Research Hospital (Ozgurhan), and Turkiye Hospital Eye Clinic (Cakir), Istanbul, Turkey.
Abstract
PURPOSE: To report the long-term results of corneal collagen crosslinking (CXL) treatment for post-laser in situ keratomileusis (LASIK) ectasia. SETTINGS: Turkiye Hospital Eye Clinic and Fatih University Medical Faculty, Department of Ophthalmology, Istanbul, Turkey. DESIGN: Retrospective case series study. METHODS: Consecutive patients with ectasia after LASIK were treated with CXL. The main outcome measures were uncorrected (UDVA) and corrected (CDVA) distance visual acuities, spherical and cylindrical refractions, and simulated keratometry (K) values. RESULTS: The study enrolled 20 eyes (14 patients; 7 women) with a mean age of 34.8 years ± 6.0 (SD) (range 25 to 45 years) and mean follow-up of 42 months (range 36 to 60 months). The UDVA and CDVA improved significantly, from 0.78 ± 0.61 logMAR to 0.53 ± 0.36 logMAR (P=.007) and from 0.27 ± 0.23 logMAR to 0.19 ± 0.13 logMAR, respectively (P≤.028). No eye lost 1 or more Snellen lines of UDVA or CDVA. Although the mean spherical refraction was not significantly different at the last visit (P=.074), the mean cylindrical refraction decreased significantly (P=.036). The maximum K value decreased from 46.0 ± 4.4 diopters (D) at baseline to 45.6 ± 3.8 D at the last visit (P=.013). By the last visit, the maximum K value decreased (≥1.0 D) in 5 eyes and remained stable in 15 eyes. No serious complications occurred. CONCLUSIONS: Corneal collagen crosslinking yielded long-term stability in cases with post-LASIK corneal ectasia without significant side effects. Improvements in visual acuity, cylindrical refraction, and maximum K values occurred. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
PURPOSE: To report the long-term results of corneal collagen crosslinking (CXL) treatment for post-laser in situ keratomileusis (LASIK) ectasia. SETTINGS: Turkiye Hospital Eye Clinic and Fatih University Medical Faculty, Department of Ophthalmology, Istanbul, Turkey. DESIGN: Retrospective case series study. METHODS: Consecutive patients with ectasia after LASIK were treated with CXL. The main outcome measures were uncorrected (UDVA) and corrected (CDVA) distance visual acuities, spherical and cylindrical refractions, and simulated keratometry (K) values. RESULTS: The study enrolled 20 eyes (14 patients; 7 women) with a mean age of 34.8 years ± 6.0 (SD) (range 25 to 45 years) and mean follow-up of 42 months (range 36 to 60 months). The UDVA and CDVA improved significantly, from 0.78 ± 0.61 logMAR to 0.53 ± 0.36 logMAR (P=.007) and from 0.27 ± 0.23 logMAR to 0.19 ± 0.13 logMAR, respectively (P≤.028). No eye lost 1 or more Snellen lines of UDVA or CDVA. Although the mean spherical refraction was not significantly different at the last visit (P=.074), the mean cylindrical refraction decreased significantly (P=.036). The maximum K value decreased from 46.0 ± 4.4 diopters (D) at baseline to 45.6 ± 3.8 D at the last visit (P=.013). By the last visit, the maximum K value decreased (≥1.0 D) in 5 eyes and remained stable in 15 eyes. No serious complications occurred. CONCLUSIONS: Corneal collagen crosslinking yielded long-term stability in cases with post-LASIKcorneal ectasia without significant side effects. Improvements in visual acuity, cylindrical refraction, and maximum K values occurred. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Authors: Hany A Khairy; Moataz F Elsawy; Khaled Said-Ahmed; Marwa A Zaki; Sameh S Mandour Journal: Int J Ophthalmol Date: 2019-11-18 Impact factor: 1.779
Authors: Alex L K Ng; Tommy C Y Chan; George P M Cheng; Vishal Jhanji; Cong Ye; Victor C P Woo; Jimmy S M Lai Journal: J Ophthalmol Date: 2016-04-27 Impact factor: 1.909
Authors: Aris Konstantopoulos; Yu-Chi Liu; Ericia P Teo; Chan L Nyein; Gary H Yam; Jodhbir S Mehta Journal: Transl Vis Sci Technol Date: 2019-05-20 Impact factor: 3.283
Authors: Virgilio Galvis; Alejandro Tello; Néstor I Carreño; Alvaro I Ortiz; Rodrigo Barrera; Carlos Julián Rodriguez; Miguel E Ochoa Journal: Ophthalmol Eye Dis Date: 2016-05-12